REMINDER: Our user survey closes on Friday, please submit your responses here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDDDD.L Share News (DDDD)

  • There is currently no data for DDDD

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRADING UPDATES: 4D Pharma warns of wind-up; Star Phoenix files claim

Fri, 05th Aug 2022 14:58

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and Wednesday and not separately reported by Alliance News:

----------

Condor Gold PLC - mine developer in Nicaragua - Gets the final results of metallurgical tests for a feasibility study conducted on the La India Open Pit. It was conducted by the Bureau Veritas Laboratories in Richmond, British Columbia. Says low-grade composites averaged 94% at the 75 micron target grind. Says study indicated a net metallurgical recovery of 91%, which will be used in the technical economic models for the forthcoming feasibility study.

----------

Novacyt SA - Surrey-based biotechnology group focused on clinical diagnostics - Launches its first fully freeze-dried direct-to-PCR assays. It enables the transportation of assays at ambient temperatures to remote regions or in areas without a centralised cold storage supply chain.

----------

Schroder British Opportunities Trust PLC - investment company - makes an additional investment into digital-first home healthcare firm Cera Care Ltd. The investment is part of a new funding round to accelerate Cera's growth. Anticipates that the funding round will lead to an uplift in the fair value of its existing holding in Cera of roughly GBP2.1 million, or an approximate uplift on its NAV of 2.8 pence per share, compared to the valuation as at March 31.

----------

MGC Pharmaceuticals Ltd - Perth, Australia-based medicinal cannabis company - Confirms that it has received the first funding tranche of USD1.2 million under its new USD10 million financing facility with Mercer Street Global Opportunity Fund LLC. It is a fund managed by Mercer Street Capital Partners LLC.

----------

Hamak Gold Ltd - British Virgin Islands-based gold exploration firm focused on Liberia - Receives positive channel sampling results at its Nimba license. Intersects significant gold mineralization from its Block-1 grid. Says the results are suggestive of a bulk tonnage gold target.

----------

Star Phoenix Group Ltd - oil and gas company focused on Trinidad and Indonesia - Says its wholly owned subsidiary Range Resources Drilling Services Ltd has submitted three claims of GBP1.8 million against Range Resources Trinidad Ltd in the Supreme Court of Trinidad and Tobago. The claims are in respect of breach of loan, service and equipment rental contracts.

----------

4D Pharma PLC - Leeds, England-based pharmaceutical company - Says its administrators have published a proposal for members and creditors. Says it is uncertain whether rescuing the company in accordance with Paragraph 3,1,a is achievable, considering the uncertainty of the ongoing sale of business process. Aims to is to achieve a better result for the company's creditors as a whole. Notes that a wind-up could be possible.

----------

Critical Metals PLC - Africa-focused natural resources investor - Enters into an investment agreement with its wholly owned subsidiary Critical Metals Mauritius Ltd, Madini Occidental Ltd, and Madini Occidental's shareholders Russell Fryer and Madini Minerals.

----------

Online Blockchain PLC - Ongar, England-based cryptocurrency firm - Adds Optimism to its portfolio of bridges. It is a Layer 2 Ethereum scaling solution has a USD1.20 billion total value locked.

----------

GreenX Metals Ltd - developing Arctic Rift copper project in Greenland - Plans to deploy three advanced all-terrain vehicles for its exploration programme at the Arctic Rift Copper project in Greenland.

----------

First Class Metals PLC - Lancashire, England-based minerals exploration company - Starts ground exploration and reconnaissance work across six of the seven properties.

----------

United Oil & Gas PLC - oil and gas company operating in Egypt, Italy and UK - Finds 7 metres of net oil pay in the Primary Abu Roash C reservoir on its Abu Sennan licence, onshore Egypt. Plans for the testing programme to include both primary and secondary Abu Roash G targets. Optimistic about its prospects, with oil prices remaining high.

----------

Power Metal Resources PLC - London-based metals exploration company focused in North America, Africa and Australia - Starts next exploration phase at its Molopo Farms Complex Project in southwest Botswana. The project is targeting nickel, copper and platinum-group-element mineralisation. The next stage is planned diamond drilling. It is focused on the discovery of economic nickel sulphides and following up on the results from the drill programme completed in 2021.

----------

By Abby Amoakuh; abbyamoakuh@alliancenews.com

Copyright 2022 Alliance News Limited. All Rights Reserved.

More News
14 May 2018 16:11

UK Shareholder Meetings Calendar - Next 7 Days

Tuesday 15 MayAmerisur ResourcesMacfarlane GroupSpirax-Sarco EngineeringAnglo Pacific

Read more
8 May 2018 10:02

4D Pharma Sets Up Phase Two Study For Bowel Syndrome Treatment Blautix

LONDON (Alliance News) - Biotherapeutics developer 4D Pharma PLC said on Tuesday that the US Food & Drug Administration has cleared the Investigational New Drug Application for irritable bowel

Read more
23 Apr 2018 09:47

4D Pharma Loss In 2017 Widens On Higher Research And Development Costs

LONDON (Alliance News) - Drug development firm 4D Pharma PLC said Monday its loss widened in 2017 on higher research and development costs as it continued to progress its pipeline and clinical in

Read more
21 Mar 2018 09:12

4D Pharma To Shortly Begin Clinical Studies On MRx0518 Treatment

LONDON (Alliance News) - 4D Pharma PLC on Wednesday said it is close to starting clinical studies on its potential MRx0518 cancer treatment.MRx0518 is a single strain a

Read more
13 Dec 2016 07:54

4D Pharma Reports Encouraging Results From Blautix Phase 1 Trial

Read more
30 Sep 2016 06:51

4D Pharma Loss Narrows As Operating And Research Costs Fall

Read more
22 Aug 2016 11:57

4D Pharma begins Thetanix phase 1 clinical trial

(ShareCast News) - Pharmaceutical company 4D pharma has begun dosing in a phase 1 clinical trial with Thetanix for the treatment of Paediatric Crohn's disease (PCD). PCD is a rare chronic inflammatory bowel disease that is caused by the malfunction of the immune system leading to inflammation, or sw

Read more
19 Jul 2016 10:00

4D Pharma announces encouraging first clinical trial of Blautix

(ShareCast News) - 4D Pharma announced a positive response from its Blautix treatment for irritable bowel syndrome (IBS) in a phase 1 clinical trial. The trial was a first in man study and, as previously reported by the company, Blautix was found to be both safe and well tolerated and achieved the p

Read more
19 Jul 2016 07:49

4D Pharma Says Positive First Trial Of Product Blautix "Encouraging"

Read more
10 Jun 2016 07:30

4D Pharma Gets Approval To Restart Thetanix Phase I Clinical Study

Read more
23 May 2016 12:49

4D Pharma irritable bowel treatment proves safe in clinical trial

(ShareCast News) - Early clinical trials of 4D Pharma's treatment for irritable bowel syndrome (IBS) have successfully shown Blautix to be safe and well tolerated. Blautix, which contains live bacteria, like all 4D's products, was delivered orally to 56 healthy volunteers and IBS patients. Data fro

Read more
23 May 2016 06:58

4d Pharma Says Blautix Treatment Meets Primary Endpoint In Trial

Read more
17 May 2016 15:11

AGM, EGM Calendar - Week Ahead

Read more
16 May 2016 15:10

AGM, EGM Calendar - Week Ahead

Read more
8 Apr 2016 16:17

4D Pharma gobbles up Biomar production assets

(ShareCast News) - 4D Pharma announced a major acquisition on Friday, gobbling up the production assets of Spanish-based contract research organisation Biomar. The AIM-traded pharmaceutical company, which focuses on the development of live biotherapeutics, said Biomar had been working as an outsourc

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.